Cardiovascular diseases are among the most common serious illnesses affecting human health. CVDs may be prevented or mitigated by early diagnosis, and this may reduce mortality rates. Identifying risk factors using machine learning models is a promising approach. We would like to propose a model that incorporates different methods to achieve effective prediction of heart disease. For our proposed model to be successful, we have used efficient Data Collection, Data Pre-processing and Data Transformation methods to create accurate information for the training model. We have used a combined dataset (Cleveland, Long Beach VA, Switzerland, Hungarian and Stat log). Suitable features are selected by using the Relief, and Least Absolute Shrinkage and Selection Operator (LASSO) techniques. New hybrid classifiers like Decision Tree Bagging Method (DTBM), Random Forest Bagging Method (RFBM), K-Nearest Neighbors Bagging Method (KNNBM), AdaBoost Boosting Method (ABBM), and Gradient Boosting Boosting Method (GBBM) are developed by integrating the traditional classifiers with bagging and boosting methods, which are used in the training process. We have also instrumented some machine learning algorithms to calculate the Accuracy (ACC), Sensitivity (SEN), Error Rate, Precision (PRE) and F1 Score (F1) of our model, along with the Negative Predictive Value (NPR), False Positive Rate (FPR), and False Negative Rate (FNR). The results are shown separately to provide comparisons. Based on the result analysis, we can conclude that our proposed model produced the highest accuracy while using RFBM and Relief feature selection methods (99.05%).

Background: Identification and treatment of breast cancer at an early stage can reduce mortality. Currently, mammography is the most widely used effective imaging technique in breast cancer detection. However, an erroneous mammogram based interpretation may result in false diagnosis rate, as distinguishing cancerous masses from adjacent tissue is often complex and error-prone. Methods: Six pre-trained and fine-tuned deep CNN architectures: VGG16, VGG19, MobileNetV2, ResNet50, DenseNet201, and InceptionV3 are evaluated to determine which model yields the best performance. We propose a BreastNet18 model using VGG16 as foundational base, since VGG16 performs with the highest accuracy. An ablation study is performed on BreastNet18, to evaluate its robustness and achieve the highest possible accuracy. Various image processing techniques with suitable parameter values are employed to remove artefacts and increase the image quality. A total dataset of 1442 preprocessed mammograms was augmented using seven augmentation techniques, resulting in a dataset of 11,536 images. To investigate possible overfitting issues, a k-fold cross validation is carried out. The model was then tested on noisy mammograms to evaluate its robustness. Results were compared with previous studies. Results: Proposed BreastNet18 model performed best with a training accuracy of 96.72%, a validating accuracy of 97.91%, and a test accuracy of 98.02%. In contrast to this, VGGNet19 yielded test accuracy of 96.24%, MobileNetV2 77.84%, ResNet50 79.98%, DenseNet201 86.92%, and InceptionV3 76.87%. Conclusions: Our proposed approach based on image processing, transfer learning, fine-tuning, and ablation study has demonstrated a high correct breast cancer classification while dealing with a limited number of complex medical images.

In recent years, lung disease has increased manyfold, causing millions of casualties annually. To combat the crisis, an efficient, reliable, and affordable lung disease diagnosis technique has become indispensable. In this study, a multiclass classification of lung disease from frontal chest X-ray imaging using a fine-tuned CNN model is proposed. The classification is conducted on 10 disease classes of the lungs, namely COVID-19, Effusion, Tuberculosis, Pneumonia, Lung Opacity, Mass, Nodule, Pneumothorax, and Pulmonary Fibrosis, along with the Normal class. The dataset is a collective dataset gathered from multiple sources. After pre-processing and balancing the dataset with eight augmentation techniques, a total of 80,000 X-ray images were fed to the model for classification purposes. Initially, eight pre-trained CNN models, AlexNet, GoogLeNet, InceptionV3, MobileNetV2, VGG16, ResNet 50, DenseNet121, and EfficientNetB7, were employed on the dataset. Among these, the VGG16 achieved the highest accuracy at 92.95%. To further improve the classification accuracy, LungNet22 was constructed upon the primary structure of the VGG16 model. An ablation study was used in the work to determine the different hyper-parameters. Using the Adam Optimizer, the proposed model achieved a commendable accuracy of 98.89%. To verify the performance of the model, several performance matrices, including the ROC curve and the AUC values, were computed as well.

No abstract

Alzheimer's disease is largely the underlying cause of dementia due to its progressive neurodegenerative nature among the elderly. The disease can be divided into five stages: Subjective Memory Concern (SMC), Mild Cognitive Impairment (MCI), Early MCI (EMCI), Late MCI (LMCI), and Alzheimer's Disease (AD). Alzheimer's disease is conventionally diagnosed using an MRI scan of the brain. In this research, we propose a fine-tuned convolutional neural network (CNN) classifier called AlzheimerNet, which can identify all five stages of Alzheimer's disease and the Normal Control (NC) class. The ADNI database's MRI scan dataset is obtained for use in training and testing the proposed model. To prepare the raw data for analysis, we applied the CLAHE image enhancement method. Data augmentation was used to remedy the unbalanced nature of the dataset and the resultant dataset consisted of 60000 image data on the 6 classes. Initially, five existing models including VGG16, MobileNetV2, AlexNet, ResNet50 and InceptionV3 were trained and tested to achieve test accuracies of 78.84%, 86.85%, 78.87%, 80.98% and 96.31% respectively. Since InceptionV3 provides the highest accuracy, this model is later modified to design the AlzheimerNet using RMSprop optimizer and learning rate 0.00001 to achieve the highest test accuracy of 98.67%. The five pre-trained models and the proposed fine-tuned model were compared in terms of various performance matrices to demonstrate whether the AlzheimerNet model is in fact performing better in classifying and detecting the six classes. An ablation study shows the hyperparameters used in the experiment. The suggested model outperforms the traditional methods for classifying Alzheimer's disease stages from brain MRI, as measured by a two-tailed Wilcoxon signed-rank test, with a significance of < 0.05.